179 related articles for article (PubMed ID: 19132974)
1. Topical glucocorticoids downregulate COX-1 positive cells in nasal polyps.
Ebbens FA; Maldonado M; de Groot EJ; Alobid I; van Drunen CM; Picado C; Fokkens WJ; Mullol J
Allergy; 2009 Jan; 64(1):96-103. PubMed ID: 19132974
[TBL] [Abstract][Full Text] [Related]
2. GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.
Hamilos DL; Leung DY; Muro S; Kahn AM; Hamilos SS; Thawley SE; Hamid QA
J Allergy Clin Immunol; 2001 Jul; 108(1):59-68. PubMed ID: 11447383
[TBL] [Abstract][Full Text] [Related]
3. Oral steroids enhance epithelial repair in nasal polyposis via upregulation of the AP-1 gene network.
Li CW; Cheung W; Lin ZB; Li TY; Lim JT; Wang DY
Thorax; 2009 Apr; 64(4):306-12. PubMed ID: 19158123
[TBL] [Abstract][Full Text] [Related]
4. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma.
Ediger D; Sin BA; Heper A; Anadolu Y; Misirligil Z
Clin Exp Allergy; 2005 Mar; 35(3):319-26. PubMed ID: 15784110
[TBL] [Abstract][Full Text] [Related]
5. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment.
Valera FC; Queiroz R; Scrideli C; Tone LG; Anselmo-Lima WT
Clin Exp Allergy; 2009 Jan; 39(1):81-8. PubMed ID: 19068102
[TBL] [Abstract][Full Text] [Related]
6. [Effects of intranasal budesonide on the infiltration and activation of eosinophils in nasal polyps].
Zhang L; Han D; Zhang Y; Zhou B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):129-32. PubMed ID: 12768671
[TBL] [Abstract][Full Text] [Related]
7. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium.
Mullol J; López E; Roca-Ferrer J; Xaubet A; Pujols L; Fernàndez-Morata JC; Fabra JM; Picado C
Clin Exp Allergy; 1997 Dec; 27(12):1432-41. PubMed ID: 9433939
[TBL] [Abstract][Full Text] [Related]
8. Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids.
Pujols L; Alobid I; Benítez P; Martínez-Antón A; Roca-Ferrer J; Fokkens WJ; Mullol J; Picado C
Allergy; 2008 Oct; 63(10):1377-86. PubMed ID: 18671773
[TBL] [Abstract][Full Text] [Related]
9. Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps.
Benson M; Carlsson L; Adner M; Jernås M; Rudemo M; Sjögren A; Svensson PA; Uddman R; Cardell LO
J Allergy Clin Immunol; 2004 Jun; 113(6):1137-43. PubMed ID: 15208596
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of regulatory and helper T-cell-associated genes in nasal polyposis.
Li CW; Zhang KK; Li TY; Lin ZB; Li YY; Curotto de Lafaille MA; Shi L; Wang DY
Allergy; 2012 Jun; 67(6):732-40. PubMed ID: 22462754
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps.
Martínez-Antón A; de Bolós C; Alobid I; Benítez P; Roca-Ferrer J; Picado C; Mullol J
Allergy; 2008 Oct; 63(10):1368-76. PubMed ID: 18547287
[TBL] [Abstract][Full Text] [Related]
12. Spatial expression of two anti-inflammatory mediators, annexin 1 and galectin-1, in nasal polyposis.
Sena AA; Provazzi PJ; Fernandes AM; Cury PM; Rahal P; Oliani SM
Clin Exp Allergy; 2006 Oct; 36(10):1260-7. PubMed ID: 17014434
[TBL] [Abstract][Full Text] [Related]
13. New immunohistologic findings on the differential role of cyclooxygenase 1 and cyclooxygenase 2 in nasal polyposis.
Gosepath J; Brieger J; Mann WJ
Am J Rhinol; 2005; 19(2):111-6. PubMed ID: 15921208
[TBL] [Abstract][Full Text] [Related]
14. Nasal mucosal expression of the leukotriene and prostanoid pathways in seasonal and perennial allergic rhinitis.
Westergren VS; Wilson SJ; Penrose JF; Howarth PH; Sampson AP
Clin Exp Allergy; 2009 Jun; 39(6):820-8. PubMed ID: 19364335
[TBL] [Abstract][Full Text] [Related]
15. Foxp3+ T regulatory cells (Tregs) are increased in nasal polyps (NP) after treatment with intranasal steroid.
Li HB; Cai KM; Liu Z; Xia JH; Zhang Y; Xu R; Xu G
Clin Immunol; 2008 Dec; 129(3):394-400. PubMed ID: 18793874
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles of nasal polyps associated with allergic rhinitis.
Wu J; Bing L; Jin H; Jingping F
Am J Otolaryngol; 2009; 30(1):24-32. PubMed ID: 19027509
[TBL] [Abstract][Full Text] [Related]
17. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study.
Ebbens FA; Georgalas C; Luiten S; van Drunen CM; Badia L; Scadding GK; Hellings PW; Jorissen M; Mullol J; Cardesin A; Bachert C; van Zele TP; Lund VJ; Fokkens WJ
Laryngoscope; 2009 Feb; 119(2):401-8. PubMed ID: 19160404
[TBL] [Abstract][Full Text] [Related]
18. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
Saitoh T; Kusunoki T; Yao T; Kawano K; Kojima Y; Miyahara K; Onoda J; Yokoi H; Ikeda K
Int Arch Allergy Immunol; 2010; 151(1):8-16. PubMed ID: 19672092
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of chronic sinus diseases by measurement of inflammatory mediators.
Van Zele T; Claeys S; Gevaert P; Van Maele G; Holtappels G; Van Cauwenberge P; Bachert C
Allergy; 2006 Nov; 61(11):1280-9. PubMed ID: 17002703
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids.
Kim YK; Uno M; Hamilos DL; Beck L; Bochner B; Schleimer R; Denburg JA
Am J Respir Cell Mol Biol; 1999 Mar; 20(3):388-97. PubMed ID: 10030836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
